TY  - GEN
AU  - McDonald,Marguerite B
AU  - Protzko,Eugene E
AU  - Brunner,Lynne S
AU  - Morris,Timothy W
AU  - Haas,Wolfgang
AU  - Paterno,Michael R
AU  - Comstock,Timothy L
AU  - Usner,Dale W
TI  - Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis
SN  - 1549-4713
PY  - 2009///0924
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Anti-Bacterial Agents
KW  - administration & dosage
KW  - Aza Compounds
KW  - Azepines
KW  - Child
KW  - Child, Preschool
KW  - Conjunctiva
KW  - microbiology
KW  - Conjunctivitis, Bacterial
KW  - drug therapy
KW  - Double-Blind Method
KW  - Female
KW  - Fluoroquinolones
KW  - Haemophilus influenzae
KW  - isolation & purification
KW  - Humans
KW  - Infant
KW  - Male
KW  - Microscopy, Acoustic
KW  - Middle Aged
KW  - Moxifloxacin
KW  - Ophthalmic Solutions
KW  - Quinolines
KW  - Staphylococcus aureus
KW  - Staphylococcus epidermidis
KW  - Streptococcus pneumoniae
KW  - Treatment Outcome
KW  - Visual Acuity
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ophtha.2009.05.014
ER  -